Shaheen; Farzana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shaheen; Farzana.The latest application filed is for "nasally administered pharmaceutical composition for the treatment of epilepsy and related disorders".

Company Profile

6.9.16

Shaheen; Farzana - Karachi N/A PK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nasally administered pharmaceutical composition for the treatment of epilepsy and related disorders Grant 11,419,833 - Shaheen , et al. August 23, 2	2022-08-23
Nasally Administered Pharmaceutical Composition For The Treatment Of Epilepsy And Related Disorders App 20210322343 - Shaheen; Farzana ; et al.	2021-10-21
Nasally Administered Pharmaceutical Composition For The Treatment Of Epilepsy And Related Disorders App 20210322344 - Shaheen; Farzana ; et al.	2021-10-21
Isoxylitones mediated neurogenesis Grant 11,065,211 - Rahman , et al. July 20, 2	2021-07-20
Anticancer peptides Grant 10,550,155 - Shaheen , et al. Fe	2020-02-04
Anticancer Peptides App 20190300572 - Shaheen; Farzana ; et al.	2019-10-03
Isoxylitones Mediated Neurogenesis App 20190290598 - Rahman; Atta-ur- ; et al.	2019-09-26
Myrtocomuloacetalone 1 as an anti-inflammatory agent Grant 9,701,690 - Mesaik , et al. July 11, 2	2017-07-11
Myrtocomuloacetalone 1 As An Anti Inflammatory Agent App 20150266889 - Mesaik; Muhammed Ahmed ; et al.	2015-09-24
Synthesis And Biological Studies Of An Isomeric Mixture Of (e/z) Isoxylitones And Its Analogues App 20150148417 - Rahman; Atta-ur- ; et al.	2015-05-28
Synthesis And Biological Studies Of An Isomeric Mixture Of (e/z) Isoxylitones And Its Analogues App 20140221682 - Rahman; Atta-ur ; et al.	2014-08-07
New alpha-glucosidase inhibitors and antibacterial compounds from Myrtus communis L. App 20080269510 - Rahman; Attaur ; et al.	2008-10-30
Anticonvulsant compounds Grant 7,399,888 - Rahman , et al. July 15, 2	2008-07-15
New Anticonvulsant Compounds App 20080004353 - Rahman; Attaur ; et al.	2008-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.